Show simple item record

Efecto antivascular de vincristina en tumor venéreo transmisible del canino

dc.creatorGonzalez, C.M.
dc.creatorCepeda, R.
dc.creatorFlores, E.
dc.creatorCattaneo, G.
dc.creatorContreras, Francisco
dc.date2006-01-01
dc.date.accessioned2019-04-03T15:31:49Z
dc.date.available2019-04-03T15:31:49Z
dc.identifierhttps://avancesveterinaria.uchile.cl/index.php/ACV/article/view/3961
dc.identifier10.5354/acv.v21i1-2.3961
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/12682
dc.descriptionAmong the more investigated antineoplastic therapeutic options, the anti-angiogenic therapy has no important collateral effects for the patient. This therapy targets the factors implied in the progress of the angiogenic cascade, to impede the vascular support of tumoral tissue, increasing the apoptosis of the neoplastic cells.In this study the changes of the vascularization of canine venereal transmissible tumor (CTVT) were studied, both in the progressive phase of growth and during regression induced by treatment with vincristine sulphate (VCR). This antineoplastic drug apart from its cytostatic effect on tumors, it has demonstrated direct antivascular effect.Histopathologically with Papanicolau stain, was observed that after the treatment, the number of blood vessels diminished significantly (pes-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherUniversidad de Chile. Facultad de Ciencias Veterinarias y Pecuariases-ES
dc.relationhttps://avancesveterinaria.uchile.cl/index.php/ACV/article/view/3961/3862
dc.sourceAvances en Ciencias Veterinarias; Vol. 21 Núm. 1-2 (2006): Enero-Diciembrees-ES
dc.source0719-5273
dc.source0716-260X
dc.titleAntivascular effect of vincristine surphate on canine transmissible veneal tumoren-US
dc.titleEfecto antivascular de vincristina en tumor venéreo transmisible del caninoes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record